← FDA Drug Approvals (Drugs@FDA)

CYTOSAR-U

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 1998-12-30

Drug application

FDA Application #

ANDA075206

Application type

Abbreviated New Drug Application (Generic)

Brand name

CYTOSAR-U

Generic name

Cytarabine

Active ingredients

CYTARABINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

TEVA PHARMS USA

First approval

1998-12-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown